Clinical Trial Update: Ozurdex Implant for Macular Edema After Treatment Failure With Anti-VEGF [NA]

View source ↗

Summary

A clinical trial evaluating Ozurdex (dexamethasone intravitreal implant) for macular edema after anti-VEGF treatment failure in retinal vein occlusion was termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Macular Edema
• Retinal Vein Occlusion

Drugs mentioned

• Ozurdex (dexamethasone intravitreal implant)

Snippet

Sponsor: Retina Research Institute, LLC | Conditions: Retinal Vein Occlusion (RVO), Macular Edema | NA | Status: TERMINATED